1.52
Amneal Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
1.41
FY23:
1.38
FY24:
1.59
FY25:
1.91
(positive)
Change from FY21 to FY25
billions USD
FY21:
2.42
FY22:
2.39
FY23:
2.09
FY24:
1.91
FY25:
1.77
Total assets
Change from FY21 to FY25
billions USD
FY21:
3.94
FY22:
3.80
FY23:
3.47
FY24:
3.50
FY25:
3.68
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.68
FY22:
0.75
FY23:
0.85
FY24:
1.13
FY25:
0.88
(negative)
Change from FY21 to FY25
billions USD
FY21:
2.90
FY22:
2.86
FY23:
2.61
FY24:
2.48
FY25:
2.87
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.36
FY22:
0.30
FY23:
0.02
FY24:
−0.11
FY25:
−0.07
Total liabilities & equity
Change from FY23 to FY25
billions USD
FY21:
–
FY22:
–
FY23:
3.47
FY24:
3.50
FY25:
3.68
All amounts in billions USD